Healthcare: Investor Brad Loncar Breaks Down ASCO 2019's Winners and Loser

37:03
 
Share
 

Manage episode 235986993 series 2394758
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.
Earlier this month, industry watchers gathered at the annual American Society of Clinical Oncology (ASCO) conference to discuss the latest research in the battle against cancer. In today's show, biotech investing expert Brad Loncar shares his key takeaways from the event, including must-hear insight into programs underway at Iovance Biotherapeutics, MacroGenics, and the biotech unicorn, Grail.

Check out more of our content here:

1429 episodes available. A new episode about every 0 hours averaging 27 mins duration .